3.25
전일 마감가:
$3.11
열려 있는:
$3.11
하루 거래량:
4,492
Relative Volume:
0.18
시가총액:
$4.84M
수익:
$27.40M
순이익/손실:
$-17.12M
주가수익비율:
-0.0304
EPS:
-106.8896
순현금흐름:
$-24.99M
1주 성능:
+3.83%
1개월 성능:
-42.27%
6개월 성능:
-42.38%
1년 성능:
-74.14%
소님 테크놀로지스 Stock (SONM) Company Profile
명칭
Dna X Inc
전화
650-378-8100
주소
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SONM
Dna X Inc
|
3.25 | 4.75M | 27.40M | -17.12M | -24.99M | -106.89 |
|
MSFT
Microsoft Corp
|
451.10 | 2.89T | 318.27B | 125.22B | 72.92B | 16.79 |
|
ORCL
Oracle Corp
|
127.56 | 345.37B | 67.36B | 17.31B | -23.69B | 5.8248 |
|
PLTR
Palantir Technologies Inc
|
122.26 | 315.32B | 5.22B | 2.29B | 2.69B | 0.8876 |
|
CRWD
Crowdstrike Holdings Inc
|
185.22 | 183.40B | 5.09B | -24.89M | 1.43B | -0.0471 |
|
FTNT
Fortinet Inc
|
154.25 | 111.64B | 7.11B | 1.95B | 2.44B | 2.5883 |
소님 테크놀로지스 Stock (SONM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-10-31 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 개시 | B. Riley FBR | Buy |
| 2019-07-09 | 업그레이드 | National Securities | Neutral → Buy |
| 2019-06-10 | 개시 | National Securities | Neutral |
| 2019-06-04 | 개시 | Lake Street | Buy |
| 2019-06-04 | 개시 | Oppenheimer | Outperform |
모두보기
소님 테크놀로지스 주식(SONM)의 최신 뉴스
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
Restriction-enzyme DNA fingerprinting method explained - Encyclopedia Britannica
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et
Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS
Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS
DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
Applied DNA Sciences Named B2i Digital Featured Company to Share BNB-Focused Treasury Shift with Investors - The National Law Review
Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com
Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView
12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
WhatsApp CEO Kunal Shah said Indians don’t value time. Sanskrit scholar responds - ThePrint
Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView
Alex Murdaugh defense points to unknown male DNA in push for new testing - 930 WFMD Free Talk
SONM Q3 2024 Earnings: Loss Narrows Significantly, Beats ExpectationsEarnings Miss Streak - newsline.com
Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant - Stock Titan
[EFFECT] DNA X, Inc. SEC Filing - Stock Titan
DNA X | EFFECT: Others - Moomoo
DNA X Inc. (SONM) Faces Downside Pressure as Support Levels ApproachRVOL Spike - newsline.com
DNA X (SONM) deregisters 350M common shares tied to Chardan resale - Stock Titan
DNA Research Shows Your Muscles Remember How Strong and Fit You Once Were - inc.com
11 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Benzinga
DNA X, Inc. (formerly Sonim Technologies) Terminates Material Definitive Agreement – SEC Form 8-K Filing June 2026 - Minichart
Sonim Technologies Ends Major Equity Purchase Agreement - TipRanks
DNA X Ends $500 Million ChEF Equity Facility and Related Registration Rights With Chardan - TradingView
DNA X (NASDAQ: SONM) terminates $500M Chardan equity facility - Stock Titan
Natera Inc stock (US6323071042): insider sales and new oncology board appointments in focus - AD HOC NEWS
DNA X: Q1 Earnings Snapshot - AOL.com
Lotus Technology Inc. Unveils Eletre X: A Revolutionary Hybrid SUV Offering 1,200+ km Range and Supercar Performance Starting at €96,990 - Quiver Quantitative
12 Information Technology Stocks Moving In Tuesday's Intraday Session - Benzinga
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Business Wire
SONMDNA X Inc Short Interest - Finviz
SONM Q3 2024 Earnings: EPS Surprises to the Upside with 22.76% Beat; Stock Rises 4%Preliminary Results - The Legal Advocate
SONM Q3 2024 Earnings: EPS Surprises Higher by 22.76%, Stock Rises Over 4%One-Time Gain Impact - The Legal Advocate
SONM Q3 2024 Earnings: EPS Beats Estimates by 22.76% Amid Cost DisciplineRetail Earnings Report - thelegaladvocate.com
DNA X Inc. (SONM) Shares Rise Nearly 6% as Buyer Interest Surges Near Key SupportBullish Sentiment - dars.gov.et
S&P 500 Edges Higher as Healthcare and Tech Rally Outweigh Utility DeclinePPI Inflation Report - thelegaladvocate.com
DNA X Inc. (SONM) Rallies 4.18% as Momentum Builds Toward Key ResistanceEntry Point Alerts - The Legal Advocate
DNA X, Inc. Enters Securities Purchase Agreement with DNA Holdings Venture, Inc. and Issues Convertible Note – Key Details and Terms - Minichart
소님 테크놀로지스 (SONM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):